.svg)
.jpeg)
Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.
Here are our introductory comments:
Dr. James Clement gave a talk on Thursday, October 3rd titled Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.
You may also like
74 - COMBINEDBrain Biobank & Our Partnership with SRF for SYNGAP1
Terry Jo Bichell, PhD, MPH
COMBINEDBrain
68 - Harnessing Messenger RNA metabolism for the development of precision gene therapy - SYNGAP1
Jeff Coller, PhD
Johns Hopkins
73 - Linking SYNGAP1 with Human-Specific Mechanisms of Neuronal Development
Pierre Vanderhaeghen, MD, PhD
VIB Center for Brain & Disease Research
